FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4529211000001102: Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26625301000001112 Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26625401000001116 Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Oxybutynin 5mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Is pack of Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has active ingredient Oxybutynin hydrochloride false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has active ingredient Oxybutynin false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has AMP Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start